Bone and joint neuropathy in rats with type-2 diabetes.
We have previously demonstrated that Goto-Kakizaki (GK) rats with spontaneous type-2 diabetes and peripheral neuropathy exhibit regional osteopathic changes. In the present study on 18 GK rats and 21 control Wistar rats, the occurrence of the sensory neuropeptides substance P (SP) and calcitonin gene-related peptide (CGRP), and the autonomic neuropeptide Y (NPY) was analysed in bone and joints, dorsal root ganglia and lumbar spinal cord by immunohistochemistry and radioimmunoassay (RIA). Immunohistochemistry disclosed a predominance of immunoreactivities in vessel-related nerve fibers, although some were also seen in free terminals. While SP, CGRP and NPY in periosteum, cortical bone and synovium was confined to neuronal tissue, the bone marrow in addition exhibited an abundance of NPY-positive megakaryocytes. Apart from this cellular source of NPY, the observations suggest that the three neuropeptides analysed in bone and joints are of neuronal origin. Quantification by RIA showed a significant decrease of NPY in cortical bone (-36%), bone marrow (-66%) and ankle (-29%) of GK rats. CGRP was decreased in the spinal cord (-19%) and dorsal root ganglia (-26%) but was unchanged in bone and joints, as with SP. Given the suggested anabolic role of NPY and CGRP on bone, neuropeptidergic deficit in diabetes may prove to be an important factor underlying the development of regional osteopenia.
Ahmad
Tashfeen
T
Section of Orthopaedics, Department of Surgical Sciences, Karolinska Institute, Stockholm, Sweden. tashfeen.ahmad@ks.se
Ugarph-Morawski
Anna
A
Li
Jian
J
Bileviciute-Ljungar
Indre
I
Finn
Anja
A
Ostenson
Claes-Göran
CG
Kreicbergs
Andris
A
D000818:Animals; D001853:Bone Marrow / Q000378:metabolism; D001842:Bone and Bones / Q000294:innervation* / Q000473:pathology; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D005260:Female; D005727:Ganglia, Spinal / Q000378:metabolism; D005951:Glucose Tolerance Test; D007150:Immunohistochemistry; D007596:Joints / Q000294:innervation* / Q000473:pathology; D009478:Neuropeptide Y / Q000378:metabolism; D009479:Neuropeptides / Q000737:chemistry; D010523:Peripheral Nervous System Diseases / Q000473:pathology*; D011863:Radioimmunoassay / Q000379:methods; D051381:Rats; D017208:Rats, Wistar; D013373:Substance P / Q000494:pharmacology
D009478:Neuropeptide Y; D009479:Neuropeptides; D013373:Substance P; D015740:Calcitonin Gene-Related Peptide